<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36722478</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1875-6190</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>3</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Current neuropharmacology</Title><ISOAbbreviation>Curr Neuropharmacol</ISOAbbreviation></Journal><ArticleTitle>Overexpression of mTOR in Leukocytes from ALS8 Patients.</ArticleTitle><Pagination><StartPage>482</StartPage><EndPage>490</EndPage><MedlinePgn>482-490</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2174/1570159X21666230201151016</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The mutated VAPBP56S (vesicle B associated membrane protein - P56S) protein has been described in a Brazilian family and classified as Amyotrophic Lateral Sclerosis type 8 (ALS8).</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">We aimed to study altered biochemical and immunological parameters in cells from ALS8 patients to identify possible biomarkers or therapeutic targets.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Wild-type VAPB, VAPBP56S, mTOR, proinflammatory cytokines, and oxidant/reducing levels in serum, leucocytes, and cellular lysate from ALS8 patients and health Controls were performed by ELISA, fluorimetry, and spectrophotometry.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our results showed similar levels of mutant and wild-type VAPB in serum and intracellular lysate (p &gt; 0.05) when ALS8 patients and Controls were compared. IL-1&#x3b2;, IL-6, and IL-18 levels in patients and Controls showed no difference, suggesting an absence of peripheral inflammation (p &gt; 0.05). Oxidative metabolic response, assessed by mitochondrial ROS production, and reductive response by MTT reduction, were higher in the ALS8 group compared to Controls (p &lt; 0.05), although not characterizing typical oxidative stress in ALS8 patients. Total mTOR levels (phosphorylated or non-phosphorylated) of ALS8 patients were significantly lower in serum and higher in intracellular lysate than the mean equivalents in Controls (p &lt; 0.05). A similar result was observed when we quantified the phosphorylated protein (p &lt; 0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We demonstrate the possibility of using these biochemical and immunological parameters as potential therapeutic targets or biomarkers. Furthermore, by hypothesis, we suggest a hormetic response in which both VAPB forms could coexist in different proportions throughout life. The mutated VAPBP56S production would increase with aging and predominate over the wild-type VAPB levels, determining the onset of symptoms and aggravating the disease.</AbstractText><CopyrightInformation>Copyright&#xa9; Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gomes</LastName><ForeName>Nath&#xe1;lia Augusta</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Stricto Sensu em Medicina/Biomedicina, Faculdade Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>das Chagas Lima E Silva</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Stricto Sensu em Medicina/Biomedicina, Faculdade Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Oliveira Volpe</LastName><ForeName>Caroline Maria</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Stricto Sensu em Medicina/Biomedicina, Faculdade Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villar-Delfino</LastName><ForeName>Pedro Henrique</ForeName><Initials>PH</Initials><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Stricto Sensu em Medicina/Biomedicina, Faculdade Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Sousa</LastName><ForeName>Camila Ferreira</ForeName><Initials>CF</Initials><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Stricto Sensu em Medicina/Biomedicina, Faculdade Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rocha-Silva</LastName><ForeName>Fabiana</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Stricto Sensu em Medicina/Biomedicina, Faculdade Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nogueira-Machado</LastName><ForeName>Jos&#xe9; Augusto</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o Stricto Sensu em Medicina/Biomedicina, Faculdade Santa Casa de BH, Belo Horizonte, Minas Gerais, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United Arab Emirates</Country><MedlineTA>Curr Neuropharmacol</MedlineTA><NlmUniqueID>101157239</NlmUniqueID><ISSNLinking>1570-159X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D033921">Vesicular Transport Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.1.1</RegistryNumber><NameOfSubstance UI="C546842">MTOR protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D058570">TOR Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C563895">Amyotrophic Lateral Sclerosis 8</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D033921" MajorTopicYN="Y">Vesicular Transport Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007962" MajorTopicYN="N">Leukocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058570" MajorTopicYN="N">TOR Serine-Threonine Kinases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS8</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">ROS</Keyword><Keyword MajorTopicYN="N">VAPB</Keyword><Keyword MajorTopicYN="N">leukocytes</Keyword><Keyword MajorTopicYN="N">mTOR</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest, financial or otherwise.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36722478</ArticleId><ArticleId IdType="pmc">PMC10207909</ArticleId><ArticleId IdType="doi">10.2174/1570159X21666230201151016</ArticleId><ArticleId IdType="pii">CN-EPUB-129222</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Souza P.V.S., Pinto W.B.V.R., Chieia M.A.T., Oliveira A.S.B. Clinical and genetic basis of familial amyotrophic lateral sclerosis. Arq. Neuropsiquiatr. 2015;73(12):1026&#x2013;1037. doi: 10.1590/0004-282X20150161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282X20150161</ArticleId><ArticleId IdType="pubmed">26465287</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Mitne-Neto M., Silva H.C.A., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R.M., Gillingwater T., Webb J., Skehel P., Zatz M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 2004;75(5):822&#x2013;831. doi: 10.1086/425287.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanekura K., Nishimoto I., Aiso S., Matsuoka M. Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8). J. Biol. Chem. 2006;281(40):30223&#x2013;30233. doi: 10.1074/jbc.M605049200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M605049200</ArticleId><ArticleId IdType="pubmed">16891305</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Bassot A., Giuliani F., Simmen T. Amyotrophic lateral sclerosis (ALS): Stressed by dysfunctional mitochondria-endoplasmic reticulum contacts (MERCs). Cells. 2021;10(7):1789. doi: 10.3390/cells10071789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071789</ArticleId><ArticleId IdType="pmc">PMC8304209</ArticleId><ArticleId IdType="pubmed">34359958</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Shen H.M., Gopalakrishnan V., Gordon N. Epigenetic regulation of autophagy beyond the cytoplasm: A review. Front. Cell Dev. Biol. 2021;9:675599. doi: 10.3389/fcell.2021.675599.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.675599</ArticleId><ArticleId IdType="pmc">PMC8237754</ArticleId><ArticleId IdType="pubmed">34195194</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin S., Liu L., Gan W. The roles of post-translational modifications on mTOR signaling. Int. J. Mol. Sci. 2021;22(4):1784. doi: 10.3390/ijms22041784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041784</ArticleId><ArticleId IdType="pmc">PMC7916890</ArticleId><ArticleId IdType="pubmed">33670113</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Pandey U.B. Autophagy dysregulation in ALS: When protein aggregates get out of hand. Front. Mol. Neurosci. 2017;10:263. doi: 10.3389/fnmol.2017.00263.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00263</ArticleId><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehorst W.A., Thelen M.P., Nolte H., T&#xfc;rk C., Cirak S., Peterson J.M., Wong G.W., Wirth B., Kr&#xfc;ger M., Winter D., Kye M.J. Muscle regulates mTOR dependent axonal local translation in motor neurons via CTRP3 secretion: Implications for a neuromuscular disorder, spinal muscular atrophy. Acta Neuropathol. Commun. 2019;7(1):154. doi: 10.1186/s40478-019-0806-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0806-3</ArticleId><ArticleId IdType="pmc">PMC6794869</ArticleId><ArticleId IdType="pubmed">31615574</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding W.X., Ni H.M., Gao W., Hou Y.F., Melan M.A., Chen X., Stolz D.B., Shao Z.M., Yin X.M. Differential effects of endoplasmic reticulum stress-induced autophagy on cell survival. J. Biol. Chem. 2007;282(7):4702&#x2013;4710. doi: 10.1074/jbc.M609267200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M609267200</ArticleId><ArticleId IdType="pubmed">17135238</ArticleId></ArticleIdList></Reference><Reference><Citation>Han S.M., El Oussini H., Scekic-Zahirovic J., Vibbert J., Cottee P., Prasain J.K., Bellen H.J., Dupuis L., Miller M.A. VAPB/ALS8 MSP ligands regulate striated muscle energy metabolism critical for adult survival in caenorhabditis elegans. PLoS Genet. 2013;9(9):e1003738. doi: 10.1371/journal.pgen.1003738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1003738</ArticleId><ArticleId IdType="pmc">PMC3764199</ArticleId><ArticleId IdType="pubmed">24039594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon M.S. mTOR as a key regulator in maintaining skeletal muscle mass. Front. Physiol. 2017;8:788. doi: 10.3389/fphys.2017.00788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2017.00788</ArticleId><ArticleId IdType="pmc">PMC5650960</ArticleId><ArticleId IdType="pubmed">29089899</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Oudart H., Ren&#xe9; F., de Aguilar J-L.G., Loeffler J.P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA. 2004;101(30):11159&#x2013;11164. doi: 10.1073/pnas.0402026101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pmc">PMC503756</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M.H., Griffiths H.R. The dual role of reactive oxygen species in autoimmune and inflammatory diseases: Evidence from preclinical models. Free Radic. Biol. Med. 2018;125:62&#x2013;71. doi: 10.1016/j.freeradbiomed.2018.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.03.016</ArticleId><ArticleId IdType="pubmed">29550327</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Suaga P., Paillusson S., Stoica R., Noble W., Hanger D.P., Miller C.C.J. The ER-mitochondria tethering complex vapb-ptpip51 regulates autophagy. Curr. Biol. 2017;27(3):371&#x2013;385. doi: 10.1016/j.cub.2016.12.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2016.12.038</ArticleId><ArticleId IdType="pmc">PMC5300905</ArticleId><ArticleId IdType="pubmed">28132811</ArticleId></ArticleIdList></Reference><Reference><Citation>Cenini G., Lloret A., Cascella R. Oxidative stress in neurodegenerative diseases: From a mitochondrial point of view. Oxid. Med. Cell. Longev. 2019;2019:1&#x2013;18. doi: 10.1155/2019/2105607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/2105607</ArticleId><ArticleId IdType="pmc">PMC6532273</ArticleId><ArticleId IdType="pubmed">31210837</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang G.M., Tan Y., Wang H., Peng L., Chen H.T., Meng X.J., Li L.L., Liu Y., Li W.F., Shan H. The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol. Cancer. 2019;18(1):17. doi: 10.1186/s12943-019-0944-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12943-019-0944-z</ArticleId><ArticleId IdType="pmc">PMC6345046</ArticleId><ArticleId IdType="pubmed">30678689</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G.Y., Sabatini D.M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 2020;21(4):183&#x2013;203. doi: 10.1038/s41580-019-0199-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-019-0199-y</ArticleId><ArticleId IdType="pmc">PMC7102936</ArticleId><ArticleId IdType="pubmed">31937935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mossmann D., Park S., Hall M.N. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat. Rev. Cancer. 2018;18(12):744&#x2013;757. doi: 10.1038/s41568-018-0074-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-018-0074-8</ArticleId><ArticleId IdType="pubmed">30425336</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxton R.A., Sabatini D.M. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960&#x2013;976. doi: 10.1016/j.cell.2017.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.02.004</ArticleId><ArticleId IdType="pmc">PMC5394987</ArticleId><ArticleId IdType="pubmed">28283069</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan P.F., Fan C., Perou C.M. Evaluating the comparability of gene expression in blood and brain. Am J Med Genet Part B, Neuropsychiatr Genet Off Publ Int Soc. Psychiatr. Genet. 2006;141B(3):261&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pubmed">16526044</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo B.G., Souza e Silva L.F., de Barros Torresi J.L., Siena A., Valerio B.C.O., Brito M.D., Rosenstock T.R. Decreased mitochondrial function, biogenesis, and degradation in peripheral blood mononuclear cells from amyotrophic lateral sclerosis patients as a potential tool for biomarker research. Mol. Neurobiol. 2020;57(12):5084&#x2013;5102. doi: 10.1007/s12035-020-02059-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-020-02059-1</ArticleId><ArticleId IdType="pmc">PMC7541388</ArticleId><ArticleId IdType="pubmed">32840822</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum J.M., Stambler N. Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J. Neurol. Sci. 1997;152(Suppl. 1):s1&#x2013;s9. doi: 10.1016/S0022-510X(97)00237-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(97)00237-2</ArticleId><ArticleId IdType="pubmed">9419047</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaka M.M. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med. J. 2012;24(3):69&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3576830</ArticleId><ArticleId IdType="pubmed">23638278</ArticleId></ArticleIdList></Reference><Reference><Citation>Deivasigamani S., Verma H.K., Ueda R., Ratnaparkhi A., Ratnaparkhi G.S. A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis. Biol. Open. 2014;3(11):1127&#x2013;1138. doi: 10.1242/bio.201410066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.201410066</ArticleId><ArticleId IdType="pmc">PMC4232771</ArticleId><ArticleId IdType="pubmed">25361581</ArticleId></ArticleIdList></Reference><Reference><Citation>Exocytosis M.A. Exocytosis. Essays Biochem. 1995;30:77&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">8822150</ArticleId></ArticleIdList></Reference><Reference><Citation>Chennampally P., Sayed-Zahid A., Soundararajan P., Sharp J., Cox G.A., Collins S.D., Smith R.L. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin. Sci. Rep. 2021;11(1):18168. doi: 10.1038/s41598-021-97405-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-97405-1</ArticleId><ArticleId IdType="pmc">PMC8438029</ArticleId><ArticleId IdType="pubmed">34518579</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauch&#xe9; S., O&#x2019;Regan S., Azuma Y., Laffargue F., McMacken G., Sternberg D., Brochier G., Buon C., Bouzidi N., Topf A., Lac&#xe8;ne E., Remerand G., Beaufrere A.M., Pebrel-Richard C., Thevenon J., El Chehadeh-Djebbar S., Faivre L., Duffourd Y., Ricci F., Mongini T., Fiorillo C., Astrea G., Burloiu C.M., Butoianu N., Sandu C., Servais L., Bonne G., Nelson I., Desguerre I., Nougues M.C., Boeuf B., Romero N., Laporte J., Boland A., Lechner D., Deleuze J.F., Fontaine B., Strochlic L., Lochmuller H., Eymard B., Mayer M., Nicole S. Impaired presynaptic high-affinity choline transporter causes a congenital myasthenic syndrome with episodic apnea. Am. J. Hum. Genet. 2016;99(3):753&#x2013;761. doi: 10.1016/j.ajhg.2016.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.06.033</ArticleId><ArticleId IdType="pmc">PMC5011057</ArticleId><ArticleId IdType="pubmed">27569547</ArticleId></ArticleIdList></Reference><Reference><Citation>Koscielny A., Liszewska E., Machnicka K., Wezyk M., Kotulska K., Jaworski J. mTOR controls endoplasmic reticulum&#x2013;Golgi apparatus trafficking of VSVg in specific cell types. Cell. Mol. Biol. Lett. 2021;26(1):18. doi: 10.1186/s11658-021-00262-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s11658-021-00262-z</ArticleId><ArticleId IdType="pmc">PMC8130434</ArticleId><ArticleId IdType="pubmed">34006213</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira D., Morales-Vicente D.A., Amaral M.S., Luz L., Serti&#xe9; A.L., Leite F.S., Navarro C., Kaid C., Esposito J., Goulart E., Caires L., Alves L.M., Melo U.S., Figueiredo T., Mitne-Neto M., Okamoto O.K., Verjovski-Almeida S., Zatz M. Different gene expression profiles in iPSC-derived motor neurons from ALS8 patients with variable clinical courses suggest mitigating pathways for neurodegeneration. Hum. Mol. Genet. 2020;29(9):1465&#x2013;1475. doi: 10.1093/hmg/ddaa069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa069</ArticleId><ArticleId IdType="pubmed">32280986</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaplot K., Pimpale L., Ramalingam B., Deivasigamani S., Kamat S.S., Ratnaparkhi G.S. SOD1 activity threshold and TOR signalling modulate VAP(P58S) aggregation via reactive oxygen species-induced proteasomal degradation in a Drosophila model of amyotrophic lateral sclerosis. Dis. Model. Mech. 2019;12(2):dmm033803. doi: 10.1242/dmm.033803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.033803</ArticleId><ArticleId IdType="pmc">PMC6398501</ArticleId><ArticleId IdType="pubmed">30635270</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto R.I. Regulation of the heat shock transcriptional response: Cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 1998;12(24):3788&#x2013;3796. doi: 10.1101/gad.12.24.3788.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.12.24.3788</ArticleId><ArticleId IdType="pubmed">9869631</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Henderson R.D. The Role of immune and inflammatory mechanisms in ALS. Curr. Mol. Med. 2011;11(3):246&#x2013;254. doi: 10.2174/156652411795243450.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652411795243450</ArticleId><ArticleId IdType="pmc">PMC3182412</ArticleId><ArticleId IdType="pubmed">21375489</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitne-Neto M., Machado-Costa M., Marchetto M.C.N., Bengtson M.H., Joazeiro C.A., Tsuda H., Bellen H.J., Silva H.C.A., Oliveira A.S.B., Lazar M., Muotri A.R., Zatz M. Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients. Hum. Mol. Genet. 2011;20(18):3642&#x2013;3652. doi: 10.1093/hmg/ddr284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr284</ArticleId><ArticleId IdType="pmc">PMC3159551</ArticleId><ArticleId IdType="pubmed">21685205</ArticleId></ArticleIdList></Reference><Reference><Citation>Trilico M.L.C., Lorenzoni P.J., Kay C.S.K., Ducci R.D.P., Fustes O.J.H., Werneck L.C., Scola R.H. Characterization of the amyotrophic lateral sclerosis-linked P56S mutation of the VAPB gene in Southern Brazil. Amyotroph. Lateral Scler. Frontotemporal Degener. 2020;21(3-4):286&#x2013;290. doi: 10.1080/21678421.2020.1738495.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1738495</ArticleId><ArticleId IdType="pubmed">32162544</ArticleId></ArticleIdList></Reference><Reference><Citation>Kj&#xe6;ldgaard A.L., Pilely K., Olsen K.S., Jessen A.H., Lauritsen A.&#xd8;., Pedersen S.W., Svenstrup K., Karlsborg M., Thagesen H., Blaabjerg M., The&#xf3;d&#xf3;rsd&#xf3;ttir &#xc1;., Elmo E.G., M&#xf8;ller A.T., Bonefeld L., Berg M., Garred P., M&#xf8;ller K. Prediction of survival in amyotrophic lateral sclerosis: A nationwide, Danish cohort study. BMC Neurol. 2021;21(1):164. doi: 10.1186/s12883-021-02187-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-021-02187-8</ArticleId><ArticleId IdType="pmc">PMC8052712</ArticleId><ArticleId IdType="pubmed">33865343</ArticleId></ArticleIdList></Reference><Reference><Citation>Longinetti E., Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 2019;32(5):771&#x2013;776. doi: 10.1097/WCO.0000000000000730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000730</ArticleId><ArticleId IdType="pmc">PMC6735526</ArticleId><ArticleId IdType="pubmed">31361627</ArticleId></ArticleIdList></Reference><Reference><Citation>Genevini P., Papiani G., Ruggiano A., Cantoni L., Navone F., Borgese N. Amyotrophic lateral sclerosis-linked mutant VAPB inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model. PLoS One. 2014;9(11):e113416. doi: 10.1371/journal.pone.0113416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0113416</ArticleId><ArticleId IdType="pmc">PMC4237408</ArticleId><ArticleId IdType="pubmed">25409455</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanhueza M., Zechini L., Gillespie T., Pennetta G. Gain-of-function mutations in the ALS8 causative gene VAPB have detrimental effects on neurons and muscles. Biol. Open. 2014;3(1):59&#x2013;71. doi: 10.1242/bio.20137070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.20137070</ArticleId><ArticleId IdType="pmc">PMC3892161</ArticleId><ArticleId IdType="pubmed">24326187</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgese N., Iacomino N., Colombo S.F., Navone F. The link between VAPB loss of function and amyotrophic lateral sclerosis. Cells. 2021;10(8):1865. doi: 10.3390/cells10081865.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081865</ArticleId><ArticleId IdType="pmc">PMC8392409</ArticleId><ArticleId IdType="pubmed">34440634</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., El Oussini H., Bercier V., Gros-Louis F., Valdmanis P.N., McDearmid J., Mejier I.A., Dion P.A., Dupre N., Hollinger D., Sinniger J., Dirrig-Grosch S., Camu W., Meininger V., Loeffler J.P., Ren&#xe9; F., Drapeau P., Rouleau G.A., Dupuis L. Investigating the contribution of VAPB/ALS8 loss of function in amyotrophic lateral sclerosis. Hum. Mol. Genet. 2013;22(12):2350&#x2013;2360. doi: 10.1093/hmg/ddt080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt080</ArticleId><ArticleId IdType="pubmed">23446633</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgese N., Navone F., Nukina N., Yamanaka T. Mutant VAPB: Culprit or innocent bystander of amyotrophic lateral sclerosis? Contact (Thousand Oaks) 2021:4. doi: 10.1177/25152564211022515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/25152564211022515</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>